至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

HIV-1-Infected CD4 T Cells Present MHC Class II-Restricted Epitope via Endogenous Processing

J Immunol. 2022-08; 
Mary M Addison, Gavin I Ellis, George J Leslie, Noah B Zawadzky, James L Riley, James A Hoxie, Laurence C Eisenlohr
Products/Services Used Details Operation
Catalog Peptides … After an initial 1.5 h of BFA treatment, 0.5 mg/ml purified Gag293 peptide (FRDYVDRFYKTLRAEQASQE) (Genscript) was added to the appropriate wells of uninfected DCs and T CD4+ s… Get A Quote

摘要

HIV-1-specific CD4 T cells (Ts) play a critical role in controlling HIV-1 infection. Canonically, Ts are activated by peptides derived from extracellular ("exogenous") Ags displayed in complex with MHC class II (MHC II) molecules on the surfaces of "professional" APCs such as dendritic cells (DCs). In contrast, activated human Ts, which express MHC II, are not typically considered for their APC potential because of their low endocytic capacity and the exogenous Ag systems historically used for assessment. Using primary Ts and monocyte-derived DCs from healthy donors, we show that activated human Ts are highly effective at MHC II-restricted presentation of an immunodominant HIV-1-derived epitope postinfection an... More

关键词